Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Harvard Business School
Dow
Merck
McKinsey

Last Updated: December 7, 2021

Volunteer for clinical trials for mangafodipir trisodium at ClinicalTrialExchange

DrugPatentWatch Database Preview

Mangafodipir trisodium - Generic Drug Details

➤ Subscribe for complete access

« Back to Dashboard

What are the generic drug sources for mangafodipir trisodium and what is the scope of freedom to operate?

Mangafodipir trisodium is the generic ingredient in one branded drug marketed by Ic Targets and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for mangafodipir trisodium
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Clinical Trials: 1
DailyMed Link:mangafodipir trisodium at DailyMed
Recent Clinical Trials for mangafodipir trisodium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institute of Neurological Disorders and Stroke (NINDS)Phase 1

See all mangafodipir trisodium clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for mangafodipir trisodium

US Patents and Regulatory Information for mangafodipir trisodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ic Targets TESLASCAN mangafodipir trisodium INJECTABLE;INJECTION 020652-001 Nov 26, 1997 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for mangafodipir trisodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ic Targets TESLASCAN mangafodipir trisodium INJECTABLE;INJECTION 020652-001 Nov 26, 1997 ⤷  Try it Free ⤷  Try it Free
Ic Targets TESLASCAN mangafodipir trisodium INJECTABLE;INJECTION 020652-001 Nov 26, 1997 ⤷  Try it Free ⤷  Try it Free
Ic Targets TESLASCAN mangafodipir trisodium INJECTABLE;INJECTION 020652-001 Nov 26, 1997 ⤷  Try it Free ⤷  Try it Free
Ic Targets TESLASCAN mangafodipir trisodium INJECTABLE;INJECTION 020652-001 Nov 26, 1997 ⤷  Try it Free ⤷  Try it Free
Ic Targets TESLASCAN mangafodipir trisodium INJECTABLE;INJECTION 020652-001 Nov 26, 1997 ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Medtronic
Express Scripts
Dow
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.